AuBuchon J P, Sandler S G, Fang C T, Dodd R Y
American Red Cross Blood Services, National Headquarters, Washington, DC.
Transfusion. 1989 Mar-Apr;29(3):230-2. doi: 10.1046/j.1537-2995.1989.29389162729.x.
The implementation of routine testing of blood donations for hepatitis B core antibody (anti-HBc) has allowed the characterization of the performance of the test in a large number of samples from apparently healthy individuals. This study reports the experience of the American Red Cross in testing 2.3 million donors for anti-HBc. The test protocol reproducibly identified a distinct population of donors. The anti-HBc-positive rate varied by region of the continental United States and by the time of year. In a case-control study, 85 percent of subsequent donations from anti-HBc-positive donors were anti-HBc positive. The predictions made in an earlier pilot study regarding the performance and impact of the test were borne out.
对献血者进行乙肝核心抗体(抗-HBc)常规检测,使得能够在大量看似健康个体的样本中对该检测的性能进行表征。本研究报告了美国红十字会对230万名献血者进行抗-HBc检测的经验。检测方案可重复性地识别出一个独特的献血者群体。抗-HBc阳性率因美国大陆地区和一年中的时间不同而有所变化。在一项病例对照研究中,抗-HBc阳性献血者随后的献血中有85%抗-HBc呈阳性。早期试点研究中关于该检测性能和影响的预测得到了证实。